View ValuationFujian Green Pine 将来の成長Future 基準チェック /16Fujian Green Pine利益と収益がそれぞれ年間15.3%と12.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に11.6% 14.4%なると予測されています。主要情報15.3%収益成長率14.44%EPS成長率Chemicals 収益成長28.8%収益成長率12.5%将来の株主資本利益率11.63%アナリストカバレッジLow最終更新日16 Jun 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 30Fujian Green Pine Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Fujian Green Pine Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026お知らせ • Jun 11Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 45 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 45 million worth of its shares. The shares will be repurchased at no more than CNY 10 per share. The purpose of the program is to cancel and reduce registered capital. The program will be funded from company's own funds. The program is subject to the shareholders’ approval. The plan will be valid for 12 months from the company's shareholders’ approval Date.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.16, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.53 per share.Buy Or Sell Opportunity • May 27Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to CN¥8.04. The fair value is estimated to be CN¥10.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 29% in the next 2 years.Board Change • May 20High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. VP & Director Yuecong Lin is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong Chinaお知らせ • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026お知らせ • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026お知らせ • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Jul 02Fujian Green Pine Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Fujian Green Pine Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025, at 15:30 China Standard Time.お知らせ • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.004 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.05 (up from CN¥0.004 loss in 3Q 2023). Revenue: CN¥528.5m (up 2.2% from 3Q 2023). Net income: CN¥25.1m (up CN¥27.2m from 3Q 2023). Profit margin: 4.7% (up from net loss in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Sep 30Now 31% overvalued after recent price riseOver the last 90 days, the stock has risen 30% to CN¥4.65. The fair value is estimated to be CN¥3.54, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in a year. Earnings are forecast to grow by 165,591% in the next year.お知らせ • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024Fujian Green Pine Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.026 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.026 (up from CN¥0.026 loss in 2Q 2023). Revenue: CN¥477.9m (down 9.3% from 2Q 2023). Net income: CN¥12.9m (up CN¥26.5m from 2Q 2023). Profit margin: 2.7% (up from net loss in 2Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Board Change • Jul 22High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Chairman & President Zhanhua Fan is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jun 29Fujian Green Pine Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Fujian Green Pine Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong ChinaNew Risk • Apr 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 30Fujian Green Pine Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024New Risk • Feb 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Feb 20Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 100 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at no more than CNY 6 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives. If the company fails to use the repurchased shares for the said purpose within 36 months of completion of the program, the unused shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.お知らせ • Dec 30Fujian Green Pine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.96 loss in 3Q 2022)Third quarter 2023 results: CN¥0.004 loss per share (improved from CN¥0.96 loss in 3Q 2022). Revenue: CN¥517.1m (down 29% from 3Q 2022). Net loss: CN¥2.18m (loss narrowed 100% from 3Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.19 loss in 2Q 2022)Second quarter 2023 results: CN¥0.026 loss per share (improved from CN¥0.19 loss in 2Q 2022). Revenue: CN¥526.9m (down 28% from 2Q 2022). Net loss: CN¥13.6m (loss narrowed 86% from 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.お知らせ • Aug 12Fujian Green Pine Co., Ltd. Announces Board AppointmentsFujian Green Pine Co., Ltd. held its 1st Extraordinary General Meeting of 2023 on 10 August 2023, approved the appointment of Lin Shida, Lin Yuecong as non-independent directors. Dong Hao, Tang Qingquan, Qian Xiaoming as independent directors, Ma Liu, Liang Yuzhan as non-employee supervisors.Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.12 loss in 1Q 2022)First quarter 2023 results: CN¥0.093 loss per share (improved from CN¥0.12 loss in 1Q 2022). Revenue: CN¥397.1m (down 42% from 1Q 2022). Net loss: CN¥47.9m (loss narrowed 22% from 1Q 2022). Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Danglun Luo was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.96 loss per share (vs CN¥0.12 loss in 3Q 2021)Third quarter 2022 results: CN¥0.96 loss per share (further deteriorated from CN¥0.12 loss in 3Q 2021). Revenue: CN¥726.2m (down 3.7% from 3Q 2021). Net loss: CN¥498.6m (loss widened CN¥436.6m from 3Q 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.17 profit in 2Q 2021)Second quarter 2022 results: CN¥0.19 loss per share (down from CN¥0.17 profit in 2Q 2021). Revenue: CN¥728.8m (down 31% from 2Q 2021). Net loss: CN¥97.3m (down 209% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 40% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 28Full year 2021 earnings released: CN¥1.77 loss per share (vs CN¥0.89 profit in FY 2020)Full year 2021 results: CN¥1.77 loss per share (down from CN¥0.89 profit in FY 2020). Revenue: CN¥3.69b (down 4.4% from FY 2020). Net loss: CN¥911.7m (down 298% from profit in FY 2020). Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥8.35, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.51 per share.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.31, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.Reported Earnings • Oct 28Third quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.26 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥754.2m (down 21% from 3Q 2020). Net loss: CN¥62.0m (down 147% from profit in 3Q 2020).Valuation Update With 7 Day Price Move • Oct 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.33, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 46% over the past year.Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.06b (down 2.8% from 2Q 2020). Net income: CN¥89.5m (down 37% from 2Q 2020). Profit margin: 8.5% (down from 13% in 2Q 2020). The decrease in margin was primarily driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥16.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 30% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.85 per share.Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.96 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥3.86b (up 33% from FY 2019). Net income: CN¥460.8m (up 1.7% from FY 2019). Profit margin: 12% (down from 16% in FY 2019). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Jan 29New 90-day low: CN¥17.52The company is down 22% from its price of CN¥22.36 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥127 per share.Is New 90 Day High Low • Jan 11New 90-day low: CN¥17.60The company is down 25% from its price of CN¥23.39 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥126 per share.Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.36, the stock is trading at a trailing P/E ratio of 19.9x, down from the previous P/E ratio of 23.7x. This compares to an average P/E of 34x in the Chemicals industry in China.Is New 90 Day High Low • Dec 12New 90-day low: CN¥20.45The company is down 3.0% from its price of CN¥21.07 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥128 per share.Valuation Update With 7 Day Price Move • Nov 21Market bids up stock over the past weekAfter last week's 15% share price gain to CN¥25.00, the stock is trading at a trailing P/E ratio of 27.2x, up from the previous P/E ratio of 23.6x. This compares to an average P/E of 40x in the Chemicals industry in China.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥475.6m, up 1.6% from the prior year. Total revenue was CN¥3.74b over the last 12 months, up 56% from the prior year.Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 17% share price decline to CN¥22.35, the stock is trading at a trailing P/E ratio of 25.3x, down from the previous P/E ratio of 30.6x. This compares to an average P/E of 40x in the Chemicals industry in China.Is New 90 Day High Low • Oct 14New 90-day high: CN¥27.00The company is up 20% from its price of CN¥22.51 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥178 per share.業績と収益の成長予測XSEC:300132 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20283,220258N/A-598112/31/20272,915220N/A777112/31/20262,556182N/A38813/31/20262,281173238298N/A12/31/20252,219153284337N/A9/30/20252,106134178226N/A6/30/20252,01875251301N/A3/31/20251,97863252297N/A12/31/20241,94055134179N/A9/30/20241,91527140189N/A6/30/20241,9040182222N/A3/31/20241,953-26119158N/A12/31/20231,969-68116157N/A9/30/20232,216-14993136N/A6/30/20232,425-645212272N/A3/31/20232,627-729212273N/A1/1/20232,917-742270341N/A9/30/20223,171-1,687191428N/A6/30/20223,199-1,251-23233N/A3/31/20223,525-1,064-28041N/A1/1/20223,693-912-33244N/A9/30/20213,776222-372-112N/A6/30/20213,9804152349N/A3/31/20214,011468323705N/A12/31/20203,865461468806N/A9/30/20203,7404767041,003N/A6/30/20203,6524628471,051N/A3/31/20203,286455765884N/A12/31/20192,908453N/A676N/A9/30/20192,392468N/A333N/A6/30/20191,909471N/A14N/A3/31/20191,499421N/A-39N/A12/31/20181,422400N/A45N/A9/30/20181,185290N/A168N/A6/30/20181,013200N/A165N/A3/31/2018911144N/A55N/A12/31/201781195N/A-5N/A9/30/201772683N/A-207N/A6/30/201765160N/A-207N/A3/31/201758740N/A-171N/A12/31/201655733N/A75N/A9/30/201655433N/A319N/A6/30/201657417N/A358N/A3/31/201658410N/A345N/A12/31/201558911N/A100N/A9/30/20156474N/A91N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 300132の予測収益成長率 (年間15.3% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 300132の収益 ( 15.3% ) CN市場 ( 26.1% ) よりも低い成長が予測されています。高成長収益: 300132の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 300132の収益 ( 12.5% ) CN市場 ( 16.1% ) よりも低い成長が予測されています。高い収益成長: 300132の収益 ( 12.5% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 300132の 自己資本利益率 は、3年後には低くなると予測されています ( 11.6 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 03:43終値2026/07/23 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fujian Green Pine Co., Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Zhuonan XuChina International Capital Corporation LimitedXiaodong YINCitic Securities Co., Ltd.Hao JiangEverbright Securities Co. Ltd.4 その他のアナリストを表示
お知らせ • Jun 30Fujian Green Pine Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Fujian Green Pine Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026
お知らせ • Jun 11Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 45 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 45 million worth of its shares. The shares will be repurchased at no more than CNY 10 per share. The purpose of the program is to cancel and reduce registered capital. The program will be funded from company's own funds. The program is subject to the shareholders’ approval. The plan will be valid for 12 months from the company's shareholders’ approval Date.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.16, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.53 per share.
Buy Or Sell Opportunity • May 27Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to CN¥8.04. The fair value is estimated to be CN¥10.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 29% in the next 2 years.
Board Change • May 20High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. VP & Director Yuecong Lin is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong China
お知らせ • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
お知らせ • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
お知らせ • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Jul 02Fujian Green Pine Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Fujian Green Pine Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025, at 15:30 China Standard Time.
お知らせ • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.004 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.05 (up from CN¥0.004 loss in 3Q 2023). Revenue: CN¥528.5m (up 2.2% from 3Q 2023). Net income: CN¥25.1m (up CN¥27.2m from 3Q 2023). Profit margin: 4.7% (up from net loss in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Sep 30Now 31% overvalued after recent price riseOver the last 90 days, the stock has risen 30% to CN¥4.65. The fair value is estimated to be CN¥3.54, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in a year. Earnings are forecast to grow by 165,591% in the next year.
お知らせ • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024Fujian Green Pine Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.026 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.026 (up from CN¥0.026 loss in 2Q 2023). Revenue: CN¥477.9m (down 9.3% from 2Q 2023). Net income: CN¥12.9m (up CN¥26.5m from 2Q 2023). Profit margin: 2.7% (up from net loss in 2Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Board Change • Jul 22High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Chairman & President Zhanhua Fan is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jun 29Fujian Green Pine Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Fujian Green Pine Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
お知らせ • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong China
New Risk • Apr 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 30Fujian Green Pine Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
New Risk • Feb 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Feb 20Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 100 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at no more than CNY 6 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives. If the company fails to use the repurchased shares for the said purpose within 36 months of completion of the program, the unused shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.
お知らせ • Dec 30Fujian Green Pine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.96 loss in 3Q 2022)Third quarter 2023 results: CN¥0.004 loss per share (improved from CN¥0.96 loss in 3Q 2022). Revenue: CN¥517.1m (down 29% from 3Q 2022). Net loss: CN¥2.18m (loss narrowed 100% from 3Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.19 loss in 2Q 2022)Second quarter 2023 results: CN¥0.026 loss per share (improved from CN¥0.19 loss in 2Q 2022). Revenue: CN¥526.9m (down 28% from 2Q 2022). Net loss: CN¥13.6m (loss narrowed 86% from 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 12Fujian Green Pine Co., Ltd. Announces Board AppointmentsFujian Green Pine Co., Ltd. held its 1st Extraordinary General Meeting of 2023 on 10 August 2023, approved the appointment of Lin Shida, Lin Yuecong as non-independent directors. Dong Hao, Tang Qingquan, Qian Xiaoming as independent directors, Ma Liu, Liang Yuzhan as non-employee supervisors.
Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.12 loss in 1Q 2022)First quarter 2023 results: CN¥0.093 loss per share (improved from CN¥0.12 loss in 1Q 2022). Revenue: CN¥397.1m (down 42% from 1Q 2022). Net loss: CN¥47.9m (loss narrowed 22% from 1Q 2022). Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Danglun Luo was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.96 loss per share (vs CN¥0.12 loss in 3Q 2021)Third quarter 2022 results: CN¥0.96 loss per share (further deteriorated from CN¥0.12 loss in 3Q 2021). Revenue: CN¥726.2m (down 3.7% from 3Q 2021). Net loss: CN¥498.6m (loss widened CN¥436.6m from 3Q 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.17 profit in 2Q 2021)Second quarter 2022 results: CN¥0.19 loss per share (down from CN¥0.17 profit in 2Q 2021). Revenue: CN¥728.8m (down 31% from 2Q 2021). Net loss: CN¥97.3m (down 209% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 40% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 28Full year 2021 earnings released: CN¥1.77 loss per share (vs CN¥0.89 profit in FY 2020)Full year 2021 results: CN¥1.77 loss per share (down from CN¥0.89 profit in FY 2020). Revenue: CN¥3.69b (down 4.4% from FY 2020). Net loss: CN¥911.7m (down 298% from profit in FY 2020). Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥8.35, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.51 per share.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.31, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.
Reported Earnings • Oct 28Third quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.26 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥754.2m (down 21% from 3Q 2020). Net loss: CN¥62.0m (down 147% from profit in 3Q 2020).
Valuation Update With 7 Day Price Move • Oct 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.33, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 46% over the past year.
Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.06b (down 2.8% from 2Q 2020). Net income: CN¥89.5m (down 37% from 2Q 2020). Profit margin: 8.5% (down from 13% in 2Q 2020). The decrease in margin was primarily driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥16.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 30% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.85 per share.
Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.96 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥3.86b (up 33% from FY 2019). Net income: CN¥460.8m (up 1.7% from FY 2019). Profit margin: 12% (down from 16% in FY 2019). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Jan 29New 90-day low: CN¥17.52The company is down 22% from its price of CN¥22.36 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥127 per share.
Is New 90 Day High Low • Jan 11New 90-day low: CN¥17.60The company is down 25% from its price of CN¥23.39 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥126 per share.
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.36, the stock is trading at a trailing P/E ratio of 19.9x, down from the previous P/E ratio of 23.7x. This compares to an average P/E of 34x in the Chemicals industry in China.
Is New 90 Day High Low • Dec 12New 90-day low: CN¥20.45The company is down 3.0% from its price of CN¥21.07 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥128 per share.
Valuation Update With 7 Day Price Move • Nov 21Market bids up stock over the past weekAfter last week's 15% share price gain to CN¥25.00, the stock is trading at a trailing P/E ratio of 27.2x, up from the previous P/E ratio of 23.6x. This compares to an average P/E of 40x in the Chemicals industry in China.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥475.6m, up 1.6% from the prior year. Total revenue was CN¥3.74b over the last 12 months, up 56% from the prior year.
Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 17% share price decline to CN¥22.35, the stock is trading at a trailing P/E ratio of 25.3x, down from the previous P/E ratio of 30.6x. This compares to an average P/E of 40x in the Chemicals industry in China.
Is New 90 Day High Low • Oct 14New 90-day high: CN¥27.00The company is up 20% from its price of CN¥22.51 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥178 per share.